STOCKSCREENR
Log In

PRN.TO

TSX

Profound Medical Corp.

$8.02+0.24(+3.08%)Mkt Cap: $242.68M

Key Stats

Market Cap

$242.68M

P/E Ratio

-4.46

EPS

$-1.80

Dividend Yield

0.00%

52-Week Range

$5.23 — $12.40

Volume

9.12K

Avg Volume

19.72K

Beta

0.39

Valuation

P/E (TTM)

-4.46

Forward P/E

—

PEG Ratio

-0.72

P/S (TTM)

16.30

P/B (TTM)

6.96

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

-0.87%

ROA (TTM)

-0.94%

ROIC

—

Gross Margin

0.72%

Operating Margin

-3.09%

Net Margin

—

Debt/Equity

0.01

Current Ratio

4.18

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

+0.09%

EPS Growth (5Y)

+0.03%

Sales Growth (3Y)

+0.18%

Sales Growth (5Y)

+0.24%

EPS Est (This Year)

$-0.95

EPS Est (Next Year)

$-0.68

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$0.82

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

30.20M

Float

28.97M

Free Float %

95.91%

About

Sector

Healthcare

Industry

Medical - Devices

Country

CA

Exchange

TSX

IPO Date

2018-07-10

Employees

142

CEO

Arun Swarup Menawat

Index Membership

—

Website

https://www.profoundmedical.com

Profound Medical Corp. (PRN.TO) is a healthcare company in the medical - devices industry listed on the TSX. With a market capitalization of $242.68M, a P/E ratio of -4.46, PRN.TO is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare PRN.TO against other stocks using dozens of fundamental and technical filters.

Similar Stocks

AVNS

Avanos Medical, Inc.

$13.61

-1.52%

$632.91M

OFIX

Orthofix Medical Inc.

$12.03

+1.35%

$482.94M

LAB

Standard BioTools Inc.

$0.98

+3.01%

$378.30M

VMD

Viemed Healthcare, Inc.

$9.69

-0.92%

$375.83M

CNMD

CONMED Corporation

$37.34

-0.19%

$1.16B

AVR

Anteris Technologies Global Corp.

$5.97

-4.78%

$219.63M

Frequently Asked Questions

What is Profound Medical Corp.'s P/E ratio?

Profound Medical Corp. (PRN.TO) has a trailing twelve-month (TTM) P/E ratio of -4.46. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Profound Medical Corp. pay a dividend?

No, Profound Medical Corp. (PRN.TO) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Profound Medical Corp.'s market cap?

Profound Medical Corp. (PRN.TO) has a market capitalization of $242.68 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.